Search tool

We aimed to estimate the associations between a history of incarceration and prevalence of HIV and HCV infection among PWID in Europe.

This report presents an overview of the drug phenomenon in Luxembourg, covering drug policy, drug supply and demand, drug use patterns, health consequences and responses, as well as drug markets and crime...

This paper aims to give an up-to-date overview on availability, coverage and policy framework of prison-based harm reduction interventions in Europe.

This knowledge questionnaire has been developed by the EMCDDA as part of its initiative to increase access to hepatitis C care through drug services. The main aims of the knowledge questionnaire are...

This page is being updated regularly with the latest information on COVID-19 for people living with viral hepatitis.

COVID-19 guidance published by the UNODC for people who use drugs and people in prison. Publisher's summary: All people have the right to health, even in countries under lockdown or where a...

The leaflet presents facts regarding hepatitis C. It includes following subjects: complication of hepatitis C, the treatment, care, pregnancy, and general information on understanding hepatitis C testing.

Hepatitis C virus (HCV) infection has a high prevalence in people who inject drugs (PWID) in Europe, although HCV infection is both preventable and curable. Effective interventions that target the prevention of...

Reaching and testing those at risk of infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV) is still a public health challenge across Europe. One in...